Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice
Author(s) -
Olivier Herbin,
Hafid Aït-Oufella,
Wang Yu,
Gunilla Nordin Fredrikson,
Benjamin Aubier,
Nicolas Pérez,
Véronique Barateau,
Jan Nilsson,
Alain Tedgui,
Ziad Mallat
Publication year - 2012
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.111.242800
Subject(s) - immune system , ovalbumin , inflammation , apolipoprotein b , immunology , medicine , adjuvant , regulatory t cell , apolipoprotein e , t cell , il 2 receptor , disease , cholesterol
The immunoinflammatory response plays a critical role in the development and progression of atherosclerosis. Recent studies suggested an important role for regulatory T (Treg) cells in the inhibition of disease-related vascular inflammation. We hypothesized that induction of a specific Treg cell response to atherosclerosis-relevant antigens would be an attractive strategy to limit the development and progression of atherosclerosis through the promotion of immune tolerance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom